Medicus Pharma issues up to $5M debentures to Yorkville at 8% interest, 90% of face value

Medicus Pharma Ltd.

Initial closing of $1.25M debentures; two additional tranches of $1.25M and up to $2.5M subject to conditions.
Debentures bear 8% annual interest (up to 18% upon default), mature Feb 2, 2026, repayable in six monthly installments of $500K each.
Issued at 90% of principal amount; optional redemption by Company, and Yorkville may require redemption with equity financing proceeds.
Subsidiaries provide global guaranty for obligations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.